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Abstract
Insects rely primarily on innate immune responses to fight pathogens. In Drosophila, antimicrobial peptides are key
contributors to host defense. Antimicrobial peptide gene expression is regulated by the IMD and Toll pathways. Bacterial
peptidoglycans trigger these pathways, through recognition by peptidoglycan recognition proteins (PGRPs). DAP-type
peptidoglycan triggers the IMD pathway via PGRP-LC and PGRP-LE, while lysine-type peptidoglycan is an agonist for the Toll
pathway through PGRP-SA and PGRP-SD. Recent work has shown that the intensity and duration of the immune responses
initiating with these receptors is tightly regulated at multiple levels, by a series of negative regulators. Through two-hybrid
screening with PGRP-LC, we identified Rudra, a new regulator of the IMD pathway, and demonstrate that it is a critical
feedback inhibitor of peptidoglycan receptor signaling. Following stimulation of the IMD pathway, rudra expression was
rapidly induced. In cells, RNAi targeting of rudra caused a marked up-regulation of antimicrobial peptide gene expression.
rudra mutant flies also hyper-activated antimicrobial peptide genes and were more resistant to infection with the insect
pathogen Erwinia carotovora carotovora. Molecularly, Rudra was found to bind and interfere with both PGRP-LC and PGRP-
LE, disrupting their signaling complex. These results show that Rudra is a critical component in a negative feedback loop,
whereby immune-induced gene expression rapidly produces a potent inhibitor that binds and inhibits pattern recognition
receptors.
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Introduction
Insects rely primarily on innate immune responses to fight
pathogens. The Drosophila immune response has proven to be an
experimentally powerful and conserved model system for the study
of innate immunity [1,2,3,4]. In particular, the insect immune
response relies on evolutionary conserved NF-kB signaling
cascades for the control of inducible antimicrobial peptide
(AMP) gene transcription. This antimicrobial peptide response is
critical for protection against many microbial pathogens [5,6].
In Drosophila, two signaling pathways regulate the production of
these antimicrobial peptides - the IMD and Toll pathways [7].
The Toll pathway responds to many Gram-positive bacterial and
fungal infections [8], while the IMD pathway is potently activated
by DAP-type peptidoglycan (PGN) from Gram-negative bacteria
and certain Gram-positive bacteria [9,10]. Two receptors, PGRP-
LC and PGRP-LE, are able to recognize DAP-type PGN at the
cell surface or in the cytosol, respectively, and trigger the IMD
pathway [11,12,13,14,15,16].
Upon binding DAP-type PGN, both PGRP-LC and PGRP-LE
multimerize and signal via a common motif in their N-terminal
domains, known as the RHIM-like domain [15,17,18]. The
RHIM-like domain is critical for signaling by either receptor, but
the mechanism(s) involved remain unclear [15]. Genetic experi-
ments suggest that the imd protein functions immediately
downstream of PGRP-LC and upstream of all other known
components of the pathway [19]. IMD associates with both
PGRP-LC and -LE, although the PGRP-LC RHIM-like motif is
not required for this interaction [15]. Nonetheless, the complexes
formed on these receptors are likely to be critical to trigger further
signal transduction.
Recent work has shown that the intensity and duration of the
immune response is tightly regulated in Drosophila. As in mammals,
over-exuberant immune responses can be detrimental, and the
proper down modulation of immunity is critical for health and
fecundity [20,21,22]. In order to keep the immune response
properly modulated, the Toll and IMD pathways are controlled at
multiple levels by a series of negative regulators. For example, the
amidases PGRP-LB and PGRP-SC reduce the immunostimula-
tory activity of PGN by digesting it [23,24]. Intracellularly, the
IMD signaling pathway is further down–regulated by Dnr1,
POSH, Caspar and the E3-ligase complex containing SkpA,
dCullin and Slimb [25,26,27,28]. Additionally, the JNK and
Relish branches of the IMD pathway are thought to mutually
inhibit each other [29,30,31].
In this study, we identify and characterize a negative feedback
regulator of the IMD pathway, dubbed rudra. Expression of rudra
was rapidly induced following immune challenge. Moreover, in
flies and cells, rudra is critical for controlling immune-induced gene
expression. Following infection, rudra mutant flies hyper-activated
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resistance to microbial infection. Using various biochemical and
genetic techniques, Rudra was found to interact with the receptors
PGRP-LC and PGRP-LE and disrupt the signaling complex
assembled on these receptors. Due to its ability to destroy this
receptor signaling complex and inhibit immune responses, rudra
was named for Shiva, the Indian god of destruction, who in his
Rudra phase of mind causes inhibition and destruction of all life
on earth.
Results
Isolation of Rudra
In order to identify potential partners and regulators of the IMD
pathway receptors, a yeast two-hybrid screen was performed with
the cytoplasmic domain of PGRP-LC as bait [32,33]. 25 strongly
interacting clones were further analyzed with a set of baits that
carried mutations in the RHIM-like domain of PGRP-LC (or
irrelevant control baits). One clone interacted strongly with the
wild-type cytoplasmic domain of PGRP-LC but weakly with the
RHIM-like mutant baits (Table 1). This clone encoded amino
acids 30–197 of CG15678, and will be referred to as rudra from
hereafter.
To confirm the yeast two-hybrid results, co-immunoprecipita-
tion experiments were performed. Using epitope tagged constructs
and transient transfection in Drosophila S2* cells, both PGRP-LE
and PGRP-LC were found to associate with Rudra (Figure 1A, E).
In a heterologous system (HEK cells), similar robust associations
were observed between Rudra and PGRP-LE or 2LC (Figure 1B,
C). The interaction between Rudra and PGRP-LE was also
readily detectable, by co-immunoprecipitation, when these
proteins were produced in a rabbit reticulocyte in vitro translation
system (Figure S1). These data demonstrate that Rudra interacts
directly with the receptors PGRP-LC and PGRP-LE.
In order to determine which domain(s) of the receptors interact
with Rudra, co-immunoprecipitation assays were performed with
various mutant versions of PGRP-LC or PGRP-LE. Consistent
with the yeast two-hybrid data, which indicated involvement of the
RHIM-like domain for interaction, a mutant form of PGRP-LE
lacking the RHIM motif (D98-113) showed little interaction with
Rudra (Figure 1A, B). Using a set of large deletions (Figure 1D),
the N-terminal cytoplasmic domain of PGRP-LC was found to be
essential for association with Rudra. Removal of the first 144
amino acids decreased Rudra interaction, while removal of nearly
the entire cytoplasmic (D1-253) domain abolished interaction. The
PGRP-LC extracellular domain was not involved in the
interaction (Figure 1E). We then attempted to map the PGRP-
LC interaction more finely with a set of mutants that span the
entire cytoplasmic domain with sequential 50 amino acid
deletions. However, Rudra co-immunoprecipitated with all of
these deletion mutants, suggesting some redundancy in the
interaction mechanism (Figure S2). The yeast two-hybrid data
suggest that some of the interacting activity involves the PGRP-LC
RHIM domain, while the larger deletions suggest another
interaction motif likely lies in the first 144 amino acids
(Figure 1D, E). Overall, we conclude that Rudra directly interacts
with the signaling domains of PGRP-LC and PGRP-LE. The
interaction with PGRP-LE is largely mediated by the RHIM motif
while the interaction with PGRP-LC appears to involve multiple,
partly redundant, mechanisms.
Induction of rudra expression
Previous microarray studies have suggested that rudra is a target
of the IMD signaling pathway [29,34,35]. In order to confirm and
extend these findings, the expression of rudra was analyzed at
various times after immune stimulation of S2* cells, by qRT-PCR.
rudra transcript was rapidly induced, peaking in 30–60 minutes
and returning to near baseline levels within 24 hours (Figure 2A).
The kinetics of rudra expression were markedly faster and more
transient than the expression of AMP genes. For example,
Diptericin mRNA levels, as measured by Northern blotting, did
not peak until 6 hours after PGN stimulation, and then remained
elevated for at least 24 hours (Figure 2A). Even though the
expression profiles of rudra and AMP genes are distinct, they both
require the NF-kB factor Relish [35,36].
Rudra is a negative regulator of IMD signaling
Next, RNAi was used to characterize the function of rudra in the
IMD pathway. S2* cells were transfected with dsRNA for rudra,
and then stimulated with PGN for various times. As monitored by
Northern blotting, antimicrobial peptide genes Diptericin (Dpt),
Attacin (Att) and Cecropin (Cec) were induced to markedly higher
Table 1. Rudra interacts with cytoplasmic domain of PGRP-LC by yeast two-hybrid.
Baits LC WT LC D172-212 LC D213-242 LC F218A DmIKK Empty vector
Prey: Rudra aa 30–197 ++++ ++ ++ ++ 22
The cytoplasmic domain of PGRP-LC was used as bait and Rudra was used as the prey in yeast two-hybrid assays. Rudra interacted well with the full cytoplasmic domain
of PGRP-LC and the yeast cells grew robustly on Ade selection plates. However, Rudra interacted weakly with several deletion and point mutants that alter the RHIM-like
domain of PGRP-LCx. ++++, robust growth; ++, slow growth, 2 no growth.
doi:10.1371/journal.ppat.1000120.t001
Author Summary
The innate immune system controls the immediate
response to infection. Innate immunity relies on germline
encoded receptors, receptors that are present at birth, to
recognize germs and trigger a protective response.
Invertebrates (i.e., insects) rely on innate immunity to
survive in microbial-rich environments, such as rotting
fruit. However, uncontrolled innate immune responses are
dangerous, leading to severe pathologies like sepsis,
inflammatory bowel diseases, and lupus. Therefore, the
intensity and duration of the innate immune response is
kept in-check by multiple regulatory mechanisms. Here,
we have identified a new feedback regulator of the
Drosophila (the fruit fly) immune response, which we call
Rudra. Using various approaches, we show that in the
absence of Rudra the innate immune system is hyper-
activated. This elevated immune response leads to better
protection against bacterial infection. On the other hand,
when present in excess, Rudra prevents the activation of
the immune response. Furthermore, we show that Rudra
turns off the immune response by binding to the receptors
that are responsible for detecting bacteria, thereby
preventing downstream responses.
Rudra, Negative Feedback Regulator of IMD Pathway
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transfected with a control lacZ dsRNA (Figure 2B). These data
suggest that rudra is a negative regulator of IMD signaling.
To further test if rudra is a negative regulator of the IMD
pathway, stable cell lines expressing rudra from a copper-inducible
promoter were selected. These cell lines were treated with copper
for 1.5 hours, to induce rudra expression, and then stimulated with
PGN for 5 hours, to stimulate the IMD pathway. rudra over-
expression potently inhibited the induction of Dpt (Figure 3A).
Also, to test if rudra negatively regulates the Toll pathway, stable
cell lines expressing rudra from the actin promoter were selected.
These cell lines were treated with SPZ-C106 for 18 hours to
stimulate the Toll pathway. rudra over-expression did not robustly
inhibit the induction of Drosomycin, as compared to its ability to
inhibit PGN-induced Diptericin expression (Figure S3). These data
demonstrate that rudra is potent inhibitor of the IMD pathway but
has little effect on Toll signaling.
Using the UAS system and a heat shock Gal4 ‘driver’,
transgenic flies that ectopically express rudra were also character-
ized. rudra expression was induced with a 1.5 hour heat shock and
then flies were challenged with E.coli. In two independent UAS-
rudra lines, IMD signaling was strongly inhibited by rudra
expression, as monitored by Northern blotting for Dpt induction
(Figure 3A). These results are consistent with the data from
cultured cells, and argue that rudra is a potent negative regulator of
the IMD pathway in vivo.
In order to phenotypically characterize the loss of rudra, a strain
carrying a P-element at position 123 in the 59 UTR of rudra
(EY00723) was analyzed [37,38,39]. First, the level of rudra
transcript in this strain was compared to an isogenic white strain, by
qRT-PCR (Figure 4A). [To isogenize mutant and wild-type
strains, EY00723 was backcrossed with the white strain for six
generations prior to these analyses]. Similar to the cell culture
data, rudra transcription was rapidly induced following infection in
wild-type flies. Again, the induction of rudra expression occurs
more rapidly, and is resolved more quickly, than does AMP gene
expression (compare Figure 4A to 4B). The transposon insertion in
the 59 UTR markedly inhibited rudra expression, with nearly
undetectable levels at all time points, demonstrating that this allele
of rudra is a strong hypomorph. Also, a transgenic rescue strain was
constructed, using a 4.5 Kbp genomic fragment (rudra
rescue). This
genomic rescue construct partially restored immune-inducible
expression of rudra, but it did not completely return to wild-type
levels (Figure 4A).
Next, the immune response of wild-type, rudra
EY00723, and the
rudra
rescue strains were compared. Diptericin expression, as monitored
by Northern blotting at various times following septic E. coli
infection, was elevated at all time points in rudra
EY00723 compared
to the isogenic wild-type strain (Figure 4B). The rudra
rescue
transgenic line restored Diptericin to levels between that observed
in the wild-type and rudra mutant flies, consistent with partially
restored levels of rudra expression observed in this line. rudra
heterozygotes also displayed elevated AMP gene expression (data
not shown). These results, together with the data from ectopic
expression, demonstrate that rudra is a potent negative regulator of
the IMD pathway in flies, as well as in cultured cell lines.
We then asked what consequence these elevated AMP levels
might have during an infection. To this end, wild-type and
rudra
EY00723 flies were infected with the Gram-negative pathogen
Erwinia carotovora carotovora (Ecc). As reported previously, Ecc is a
mildly pathogenic infection in wild-type animals, such that most
flies succumb over the course ,10 days (Figure 4C) [27,40]. As
expected, PGRP-LE; PGRP-LC double mutant flies, which lack both
receptors involved in detecting DAP-type PGN, were rapidly killed
by this infection (P=0.0252, compared to wild-type animals). On
the other hand, rudra mutants showed significantly improved
survival compared to wild-type flies (P=0.0052). These results
show that loss of rudra, and the ensuing increase in AMP levels,
enhances resistance to this Gram-negative pathogen.
Figure 2. rudra, a negative feedback regulator of IMD signaling
in cells. (A) Real-time RT-PCR analysis of rudra transcript from S2* cells
which were stimulated with PGN for various times. Diptericin expression
was quantified, by Northern blot, from these same cells. (B) Northern
blot of Diptericn, Attacin, Cecropin and rp49 expression in S2* cells
treated with lacZ dsRNA or Rudra dsRNA, and then stimulated with PGN
for various times. Data are representative of at least three independent
assays. Error bars in (A) represent standard deviation on 3 technical
repeats.
doi:10.1371/journal.ppat.1000120.g002
Figure 1. Rudra interacts with the receptors PGRP-LE and PGRP-LC. (A, B) Immunoprecipitation (IP) and immunoblot (IB) analysis of lysates
from S2
* or HEK cells transiently transfected with expression plasmids for FLAG-tagged PGRP-LE and/or T7-tagged rudra. In the Drosophila S2* cells,
the copper inducible metallothionein promoter was used for expression and cells were treated with CuSO4 or left untreated, as indicated. (C) Similar
co-immunoprecipitation experiments from lysates of HEK cells transiently co-transfected with T7-tagged PGRP-LCx and FLAG-tagged rudra expression
plasmids. (D) Schematic representation of the PGRP-LCx deletions mutants used in (E). (E) IP-IB analysis of lysates from S2
* cells transiently
transfected with metallothionein promoter expression plasmids encoding wild-type and deletion mutants of V5-tagged PGRP-LCx and FLAG-tagged
rudra, with or without CuSO4treatment, as indicated. Data are representative of at least three independent assays.
doi:10.1371/journal.ppat.1000120.g001
Rudra, Negative Feedback Regulator of IMD Pathway
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We next sought to determine the molecular mechanism(s) used
by Rudra to control signal transduction. Relish, the NF-kB
precursor protein essential for IMD triggered gene expression, is
regulated by immune-induced cleavage and phosphorylation
([41,42], unpublished data D.E-H. and N.S). Rudra expression
prevented both the cleavage and phosphorylation of Relish
(Figure 5A). Recently, we also discovered that imd protein is
rapidly cleaved following immune stimulation (unpublished data,
N.P. and N.S) and expression of rudra potently inhibits this
cleavage (Figure 5A). These results suggest that Rudra functions
upstream of Relish activation and IMD cleavage.
AMP gene expression can be triggered by ectopically expressing
certain components of the IMD pathway. In particular, over-
expressionofeitherofthereceptors,PGRP-LCorPGRP-LE,orimdis
sufficient to drive AMP gene expression. Likewise, over-expression
of the caspase Dredd is sufficient to drive Relish cleavage. To further
analyze the position that Rudra acts in the IMD pathway, it was
over-expressed with these signaling components in doubly selected
stable cell lines. Rudra potently inhibited signaling induced by over-
expression of the receptors PGRP-LC or PGRP-LE, but had no
effect on the induction of Diptericin expression caused by IMD over-
expression (Figure 5B). Likewise, Rudra did not inhibit Relish
cleavage caused by over-expressing the caspase Dredd (Figure 5C).
These results suggest that Rudra functions upstream of Dredd and
IMD, but downstream of the receptors, and is consistent with
binding data demonstrating an association between Rudra and
either PGRP-LC or PGRP-LE.
Figure 3. Over-expression of rudra blocks IMD signaling in both cells and flies. (A) Northern blot of Dpt and rp49 expression in S2
* cells
stably transfected with a metallothionein promoter–driven transgene expressing rudra. Cells were treated with CuSO4 for 1.5 hours and then
stimulated with PGN for 5 hours, as indicated. (B) Northern blot of Diptericin and rp49 expression in adult flies carrying UAS promoter–driven
transgenes expressing rudra (two independent transgenic lines). Flies were heat shocked for 1.5 hours and then RNA was isolated 8 hours after septic
infection with E.coli. Data are representative of at least three independent assays.
doi:10.1371/journal.ppat.1000120.g003
Rudra, Negative Feedback Regulator of IMD Pathway
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to IMD. The IMD association was detected by transient transfection/
co-immunoprecipitation assays, in either S2* cells (data now shown)
or HEKcells(Figure 6A).On the other hand, Rudra did not associate
with dFADD, another factor known to interact with IMD. In all,
these data argue that Rudra directly interacts with both IMD and the
receptors PGRP-LC and PGRP-LE.
These results suggest two possible models for the inhibition of
IMD signaling by Rudra: (1) Rudra may associate with both the
receptor and its signaling adaptor (IMD), holding them together in
an inactive confirmation; or (2) Rudra may interact with both
PGRP-LC and IMD separately, disrupting the association
between the receptor and its adaptor. To probe these possibilities,
co-immunoprecipitation experiments were performed with lysates
from cells co-transfected with PGRP-LC (T7 tag), imd (FLAG
tagged) and/or rudra (also FLAG tagged). In assays with just the
receptor and either IMD or Rudra, PGRP-LC interacted with
either the adaptor or the inhibitor, in both Drosophila and human
cells (Figure 6B, C). However, when all three proteins were
simultaneously co-expressed, PGRP-LC and Rudra still robustly
co-precipitated, but the association between IMD and the receptor
was markedly reduced. These data suggest that Rudra interferes
with the interaction between PGRP-LC and IMD, and this
disruption provides a molecular mechanism explaining how Rudra
down-modulates IMD signaling at the level of the receptor,
consistent with the functional and binding data presented.
Discussion
Recent work has shown that the intensity and duration of the
immune response is tightly regulated in Drosophila
[23,24,25,27,28]. Over-exuberant immune responses can be
dangerous and the proper down modulation of immunity is
important for health and fecundity [20,22]. To keep the immune
response properly modulated, the Toll and IMD pathways are
controlled at multiple levels by multiple negative regulators. In this
study, we have characterized a new negative feedback regulator of
the IMD pathway. rudra transcript is rapidly induced following
septic infection, and rudra mutant flies or rudra knockdown cells
over-express antimicrobial peptides. In the case of Erwinia carotovora
carotovora infection, this elevated level of AMP production leads to
increased survival. A similar phenotype was reported for mutants
lacking Caspar, which is thought to inhibit downstream signaling
events [27]. The results presented here, in cells and flies,
demonstrate that rudra is a key component in a negative feedback
loop that keeps the IMD pathway in check.
In addition to these loss-of-function results, over-expression of
rudra potently blocked signaling through the IMD pathway, both in
cells and in flies. Moreover, we exploited this activity to analyze
which steps in the IMD pathway are inhibited by Rudra. Using
various molecular assays to monitor different PGN-induced events
in the IMD pathway, we found that Rudra interfered with
cleavage of IMD. Signaling mediated by receptor over-expression
was also inhibited by Rudra, but this was not the case for signaling
induced by over-expression of downstream components. Together,
these data strongly support the notion that Rudra interferes with
receptor function and is consistent with the association between
Rudra and the receptors PGRP-LC or PGRP-LE.
Using assays in yeast, Drosophila, human cells and in vitro, Rudra
was shown to interact directly with PGRP-LC and PGRP-LE. The
interaction between PGRP-LE and Rudra required the RHIM-
like domain of PGRP-LE, which is also critical for signaling by this
receptor. However, the region through which PGRP-LC interacts
with Rudra is less clear and likely involves multiple, partly
redundant interfaces. Rudra also interacted with the imd protein.
Moreover, Rudra interfered with the interaction between the
receptor PGRP-LC and IMD, destabilizing the receptor signaling
complex. From these results, we propose that Rudra is a negative
feedback regulator that down modulates the IMD pathway by
binding the receptors and interrupting the associations with their
cognate signaling adaptor IMD. This regulatory loop is critical to
properly regulate the immune response.
In agreement with the data presented here, Kleino et al. (2008)
recently reported that rudra/CG15678 is a negative regulator of
the IMD pathway, although they refer to this gene as poor Imd
response upon knock-in (pirk). They showed that rudra/pirk is rapidly
Figure 4. Characterization of rudra mutant flies. (A) Real-time RT-
PCR analysis of rudra transcript from w
1118, rudra
EY00723, and rdr
rescue flies
that were infected with E.coli for various times. (B) Quantified Northern
blotting data of Diptericin and rp49 expression in w
1118, rudra
EY00723 and
rudra
rescue flies following infection with E.coli.( C) Survival assays were
performed following infection of w
1118, rudra
EY00723 and LE
112;LC
DE flies
with E. carotovora carotovora. Infected animals were incubated at 29uC
and the number of surviving flies were counted every 24 hours. Survival
data is presented in Kaplan-Meier plots and significance was analyzed
by log-rank test. (A) and (B) are representative of at least 3 independent
experiments, while (C) is representative of 2 independent trials, with 60
or 100 animals.
doi:10.1371/journal.ppat.1000120.g004
Rudra, Negative Feedback Regulator of IMD Pathway
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* cells stably transfected with a metallothionein
promoter plasmid expressing T7-tagged rudra, with or without treatment with CuSO4 and PGN, as indicated. IMD cleavage was analyzed by IP-IB
(upper panel), while Relish phosphorylation and cleavage were analyzed by immunoblotting (in the middle two panels). The asterisk marks heavy
chain detected by the secondary antibody. The lowest panel confirms Rudra expression with anti-T7 IB. (B) Northern blot of Diptericin and rp49
expression levels in S2
* cells stably transfected with metallothionein promoter–driven transgenes expressing PGRP-LCx, PGRP-LE,o rimd, with or
without concurrent expression of rudra. Cells were treated with CuSO4 (+) or left untreated (2), and RNA was extracted after 6 hours. (C) Immunoblot
analysis of Relish cleavage from S2
* cells stably transfected with metallothionein promoter expression plasmid for Dredd, with or without concurrent
expression of FLAG-tagged rudra. CuSO4 was added, for 5 hours, to induce transgene expression, as indicated. Data are representative of at least
three independent assays.
doi:10.1371/journal.ppat.1000120.g005
Rudra, Negative Feedback Regulator of IMD Pathway
PLoS Pathogens | www.plospathogens.org 7 August 2008 | Volume 4 | Issue 8 | e1000120Figure 6. Rudra disrupts the interaction between PGRP-LCx and IMD. (A) IP-IB analysis of lysates of HEK cells transiently transfected with
expression plasmids for FLAG-tagged imd or FLAG-tagged dFADD and T7-tagged rudra. Rudra interacted with IMD but not dFADD. (B, C) Similar co-
immunoprecipitation experiments from lysates of HEK cells (B) or S2* cells (C) simultaneously co-transfected with T7 tagged PGRP-LCx, FLAG tagged
IMD and/or FLAG-tagged rudra. Rudra interfered with the association between PGRP-LC and IMD. Data are representative of at least three
independent assays. Data are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1000120.g006
Rudra, Negative Feedback Regulator of IMD Pathway
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further demonstrated that rudra induction is dependent on Relish,
both in cells and in flies. Using reporter assays in S2 cells, they
found that Pirk inhibits IMD signaling but not the Toll pathway.
With transgenic RNAi fly lines, they also found that knockdown of
pirk caused the hyper-expression of the antimicrobial peptide
genes. Also, flies over-expressing Pirk blocked the activation of the
IMD pathway and were more susceptible infection. These results
are consistent with the data presented here, although we have
characterized a mutant allele of rudra and additionally show that
this mutant exhibits enhanced protection against Erwinia infection.
The data presented here also expand on the findings of Kleino et
al. (2008) by showing that Rudra not only interacts with both
PGRP-LC and IMD, but also that these interactions with Rudra
disrupt the direct association between PGRP-LC and IMD.
Kleino et al. (2008) reported that central portion of Rudra consists
of two repetitive amino acid elements of unknown function and
structure, which they named the Pirk domain. The Pirk domain is
required for the interaction with IMD, but not with PGRP-LC.
Rudra does not contain obvious homology to any other protein
motifs, and no mammalian homologs are readily detected. [36].
Recently, multiple mechanisms involved in regulating the
Drosophila immune response have come to light. Given that it is
well-established that immune activation in flies has a cost, such as
reduced fecundity [20,22] and hypersensitivity to infection
[23,24,27,43,44], it is not surprising that multiple negative
regulatory circuits control the immune response. Similarly, in
mammals, innate and adaptive immune responses are held in
check by multiple mechanisms, in order to prevent inflammatory
and autoimmune diseases while at the same time allowing an
effective response to infection. Future studies will address the
possible negative consequences of the lack of proper IMD
regulation observed in the rudra mutant animals.
Materials and Methods
Reagents
Insoluble PGN from E. coli was purchased from Invivogen.
Fly stocks and survival experiment
rudra mutant line, EY00723, was originally isolated by the
Drosophila Genome Project gene disruption consortium and
provided by the Bloomington Drosophila Stock Center. The flies
were backcrossed for six generations to a w
1118 strain in order to
isogenize. In all experiments, rudra
EY00723 mutants were compared
to isogenic w
1118 animals. PGRP-LE
112;;PGRP-LC
DE, double
mutant flies were reported previously [45]. Survival experiments
were performed with 60 flies at 29uC, following infection by
pricking in the abdomen with a microsurgery needle dipped into a
concentrated pellet of Erwinia carotovora carotovora 15 [24]. Surviving
flies were transferred to fresh vials and counted daily, until all wild-
type flies died. Kaplan-Meier plots are presented and P-values
were calculated by log-rank test using GraphPad Sigma Plot.
RNA analysis and RT-PCR
Total RNA from flies or cultured cells was isolated with the
TRIzol reagent (Invitrogen) as described previously [33]. Expres-
sion of Diptericin, Attacin, Cecropin and the control rp49 (ribosomal
protein) was analyzed by Northern blotting [33]. Northern blots
were quantified with a phosphoimager (Fuji) and AMP gene
expression was normalized to rp49 levels. For qRT-PCR, RNA
was DNase treated and re-extracted with phenol-chloroform.
cDNA was synthesized using Superscript II (Invitrogen) and
quantitative PCR analysis was performed on a DNA engine
Opticon 2 cycler (MJ Research, Watertown MA) using SYBR
Green (Biorad). The specificity of amplification was assessed for
each sample by melting curve analysis and relative quantification
was performed using a standard curve with dilutions of a standard.
The quantified data was normalized to rp49 levels. In all S2*-based
cell experiments, cells were pre-treated with 1 mM 20-hydro-
xyecdysone for 24 to 40 hr before treatment with 500 mM
CuSO4 and/ or PGN (100 ng/ml).
RNAi experiments
dsRNA was generated and purified as reported previously [46].
Cells were split 24 hours after transfection to 1.0610
6/mL and
then were treated with 1 mM 20-hydroxyecdysone. After
24 hours, cells were treated (or left untreated) with PGN
(100 ng/ml) for various time, as indicated.
Co-immunoprecipitation and immunoblotting assays
In vitro translation was performed following the protocol of the
manufacturer (Promega). Immunoprecipitations were carried out
with rabbit anti-T7 (Bethyl labs) in lysis buffer (20 mM Tris at
pH 7.6, 150 mM NaCl, 2 mM EDTA, 10% Glycerol, 1% Triton
X-100, 1 mM DTT, NaVO4, glycerol 2-phosphate and protease
inhibitors). For immunoprecipitation from cells, Schneider S2*
cells were first transfected by calcium phosphate method with
appropriate expression plasmids. Cells were split 24 hours after
transfection to 1.0610
6/mL and 24 hours later, were treated with
500 mM copper sulphate for 5 hr, when necessary, for expression
from the metallothionein promoter. Immunoprecipitations were
performed in lysis buffer and analyzed by SDS-PAGE followed by
immunoblot analysis with anti-T7 MAb (Novagen), anti-V5
(Sigma), anti-IMD (gift of J.-M. Reichhardt) or anti-Flag (Sigma)
antibodies. Stable cell lines and immunoblotting were performed
as described previously [33]. The generation and characterization
of phospho-specific Relish antibody will be detailed elsewhere (D.
E.-H. and N.S., unpublished data).
Transgenesis and analysis of UAS-rudra and genomic
rescue strains
For the UAS transgenic, the rudra ORF was amplified by PCR
and subcloned into the EcoRI and BglII sites of pUAST. For
genomic rescue, a BAC clone (Drosophila Resource Center [47])
was used as a template to amplify a 4.5 Kbp genomic fragment
containing the complete rudra locus plus flanking sequences, which
was then cloned into the EcoRI and BamHI sites of pCaSpeR [48].
After sequence verification, standard techniques were used for P-
element–mediated transformation at the MGH Drosophila
transgenics facility. For immune stimulation assays, adults (males
and females in equal numbers), were infected by pricking in the
abdomen with a microsurgery needle dipped into a concentrated
pellet of E. coli (1106), RNA was extracted 8 h later, and assayed
by Northern blotting.
Stable cell lines
The rudra gene was cloned into pRmHa3 vector by standard
methods to create constructs expressed from the metallothionein
promoter. The constructs were then transfected into S2* cells in
conjunction with pHs-Neo at a ratio of 50:1; stable transfectants
were then selected with G418 (1 mg/ml). For double stable cell
lines, the rudra expression plasmid was transfected into S2* cell
lines that were previously selected to carry plasmids expressing
either PGRP-LC, PGRP-LE, IMD or Dredd. The rudra plasmid was
selected with a second selectable marker, either G418 (1 mg/ml)
or hygromycin (20 U/ml), as appropriate.
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Figure S1 PGRP-LE and Rudra interact in vitro Co-immuno-
precipitation of in vitro co-translated PGRP-LE and Rudra. Co-
immunoprecipitation was performed using anti-FLAG antibodies
with
35S-methionine labeled in vitro translated T7-Rudra and
FLAG-PGRP-LE.
Found at: doi:10.1371/journal.ppat.1000120.s001 (3.77 MB TIF)
Figure S2 Rudra interacts with all the deletion mutants
spanning the cytoplasmic domain of PGRP-LCx. IP-IB analysis
of lysates from S2* cells transiently transfected with metallothio-
nein promoter expression plasmids encoding T7-tagged PGRP-LCx
(wild-type and deletion mutants) and FLAG-tagged rudra with or
without CuSO4 treatment, as indicated. Lower diagram indicates
the regions deleted in each mutant form of PGRP-LC.
Found at: doi:10.1371/journal.ppat.1000120.s002 (0.87 MB TIF)
Figure S3 Rudra inhibits IMD signaling but not the Toll
pathway. Northern blot of Drosomycin and Diptericin expression in
S2* cells stimulated with SPZ-C106 or PGN, respectively, with
rp49 as a loading control. Cells expressing rudra, from the actin
promoter, failed to respond to PGN but displayed robust SPZ-
induced Drosomycin expression. Stimulation time as indicated.
Found at: doi:10.1371/journal.ppat.1000120.s003 (4.55 MB TIF)
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